investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
TOR Kinase Inhibitors for Leukemia Therapy: Mechanisms of Action and Resistance
David A Fruman
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Nahum Sonenberg
McGill University
Montreal, Canada
David A Fruman
University of California, Irvine
Irvine, United States
Related projects
Nicola J Camp
Genetic Epidemiology of Chronic Lymphocytic Leukemia
Leukaemia
Hematology and hematologic malignancies
Pathology
Stephanie J Lee
Improving Outcomes Assessment in Chronic Graft versus Host Disease
Leukaemia
Hematology and hematologic malignancies
Javier Adachi
Identification of the Gastro-Intestinal Microbiota in Patients with Leukemia at MD Anderson, in Texas and INEN, Peru
Leukaemia
Hematology and hematologic malignancies
Pathology
Martine Extermann
Decision Models to Compare Treatments in Older Patients with AML
Leukaemia
Hematology and hematologic malignancies
James C Paulson
In vivo Targeting of Hematopoetic Cells With Glycan Ligands of Siglecs
Leukaemia
Hematology and hematologic malignancies
Rainer F Storb
Hematopoietic Chimerism after Stem Cell Allografts
Leukaemia
Hematology and hematologic malignancies
Richard A Flavell
Understanding Hemotopoietic Neoplasias using Humanized Mice
Leukaemia
Hematology and hematologic malignancies
Pathology
Ronald Hoffman
Myeloproliferative Disorders (MPD) Research Consortium
Leukaemia
Hematology and hematologic malignancies
Pathology
Catherine Ju-Ying Wu
Defining the Impact of Clonal Evolution on Chronic Lymphocytic Leukemia
Leukaemia
Hematology and hematologic malignancies
Pathology
